Inventor · disambiguated record
Diane Michelle Senchyna
Also filed as: SENCHYNA DIANE MICHELLE
5 granted patents·4 pending applications·14 citations·filing 2003–2018
74Inventor score
Files withALCON RES LTD2ARROWHEAD PHARMACEUTICALS INC2OCULEVE INC2ARROWHEAD RES CORP1SENSCO TECHNOLOGIES INC1
Top patents by PatentIndex Score
9 records- 0184US7732421B2RNAI-mediated inhibition of tumor necrosis factor α-related conditionsALCON RES LTD·Filed 2007·Granted Jun 8, 2010·4 cites·12 claims
- 0275US7381708B2Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eyeSENSCO TECHNOLOGIES INC·Filed 2003·Granted Jun 3, 2008·8 cites·7 claims
- 0371US10918864B2Intranasal stimulation for treatment of meibomian gland disease and blepharitisOCULEVE INC·Filed 2017·Granted Feb 16, 2021·2 cites·24 claims
- 0467US2019032061A1RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related ConditionsARROWHEAD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0566US9447419B2RNAi-mediated inhibition of tumor necrosis factor α-related conditionsARROWHEAD RES CORP·Filed 2014·Granted Sep 20, 2016·0 cites·12 claims
- 0662US2013338213A1RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONSALCON RES LTD·Filed 2013·Application pending·0 cites
- 0761US2016369283A1RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related ConditionsARROWHEAD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0858US8541389B2RNAi-mediated inhibition of tumor necrosis factor α-related conditionsYANNI JOHN M·Filed 2011·Granted Sep 24, 2013·0 cites·6 claims
- 0942US2018161579A1Extranasal stimulation devices and methodsOCULEVE INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Diane Michelle Senchyna files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →